Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory Properties
Authors:
- Belmiro ParadaBPBelmiro Parada
- Flávio ReisFlávio Reis
- Ângela PintoÂPÂngela Pinto
- José SerenoJSJosé Sereno
- Maria Xavier-CunhaMXMaria Xavier-Cunha
- Paula NetoPNPaula Neto
- Petronila Rocha-PereiraPRPetronila Rocha-Pereira
- Alfredo MotaAMAlfredo Mota
- Arnaldo FigueiredoAFArnaldo Figueiredo
- Frederico TeixeiraFTFrederico Teixeira
Open Access
- 9 July 2012
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 13 (7) , 8482-8499
Abstract
To investigate the anti-carcinogenic effects of Atorvastatin (Atorva) on a rat bladder carcinogenesis model with N-butyl-N-(4-hydroxibutil)nitrosamine (BBN), four male Wistar rat groups were studied: (1) Control: vehicle; (2) Atorva: 3 mg/kg bw/day; (3) Carcinogen: BBN (0.05%); (4) Preventive Atorva: 3 mg/kg bw/day Atorva + BBN. A two phase protocol was used, in which the drug and the carcinogen were given between week 1 and 8 and tumor development or chemoprevention were expressed between week 9 and 20, when the bladders were collected for macroscopic, histological and immunohistochemical (p53, ki67, CD31) evaluation. Serum was assessed for markers of inflammation, proliferation and redox status. The incidence of bladder carcinoma was: control 0/8 (0%); Atorva 0/8 (0%); BBN 13/20 (65%) and Atorva + BBN 1/8 (12.5%). The number and volume of tumors were significantly lower in the Atorva + BBN group, with a marked reduction in hyperplasia, dysplasia and carcinoma in situ lesions. An anti-proliferative, anti-inflammatory and antioxidant profile was also observed in the preventive Atorva group. p53 and ki67 immunostaining were significantly increased in the BBN-treated rats, which was prevented in the Atorva + BBN group. No differences were found for CD31 expression. In conclusion, Atorvastatin had a clear inhibitory effect on bladder cancer development, probably due to its antioxidant, anti-proliferative and anti-inflammatory properties.Keywords
This publication has 58 references indexed in Scilit:
- Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31Libyan Journal of Medicine, 2011
- Antioxidant effects of green tea and its polyphenols on bladder cellsLife Sciences, 2008
- Statins in tumor suppressionCancer Letters, 2008
- The effectiveness of retinoic acid treatment in bladder cancer: Impact on recurrence, survival and TGFα and VEGF as end-point biomarkers.Cancer Biology & Therapy, 2008
- Null mutation for Macrophage Migration Inhibitory Factor (MIF) is associated with less aggressive bladder cancer in miceBMC Cancer, 2007
- The Cardioprotective Effect of a Statin and Cilostazol Combination: Relationship to Akt and Endothelial Nitric Oxide Synthase ActivationCardiovascular Drugs and Therapy, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Statins and cancer preventionNature Reviews Cancer, 2005
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005